ESMO – European Society for Medical Oncology shared a post on LinkedIn:
“Apply now.
The ‘ESMO Advanced Course on ADC Development, Therapeutic Applications and Research: Thoracic and Genitourinary Cancers’.
The Course will be exploring:
- The insights on ADCs drug development.
- The mechanism of action of the most common ADCs used in clinical practice.
- The integration of ADCs in current clinical practice guidelines across pathologies.
- Guidance on management of toxicities of ADCs.
Taking place in Zurich, Switzerland, on 25-26 November 2024
Application deadline: 8 October 2024.”
Source: ESMO/LinkedIn